Literature DB >> 20568103

Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.

Marc Arbyn1, Jerome Antoine, Margit Mägi, Giedre Smailyte, Aivars Stengrevics, Ofelia Suteu, Zdravka Valerianova, Freddie Bray, Elisabete Weiderpass.   

Abstract

The burden of cervical cancer varies considerably in the European Union (EU). In this article, we describe trends in incidence of and mortality from this cancer in the two most affected areas: the Baltic countries (Estonia, Latvia and Lithuania) and Southeast Europe (Bulgaria and Romania). Incidence data were obtained from the national cancer registries. Data on population and number of deaths from uterine cancers were extracted from the World Health Organization mortality database. Mortality rates were corrected for inaccuracies in the death certification of not otherwise specified uterine cancer. Joinpoint regression was used to study the annual variation of corrected and standardized incidence and mortality rates. Changes were assessed by calendar period and age group, whereas the evolution by birth cohort was synthesized by computing standardized cohort incidence/mortality ratios. Joinpoint regression revealed rising trends of incidence (in Lithuania, Bulgaria and Romania) and of mortality (in Latvia, Lithuania, Bulgaria and Romania). In Estonia, rates were rather stable. Women born between 1940 and 1960 were at continuously increasing risk of both incidence of and mortality from cervical cancer. Although some quality issues in the registration of cancer and causes of death cannot be ignored, the trends indicate increased exposure to human papillomavirus infection and absence of effective screening programs. Rising trends of cervical cancer in the most affected EU member states reveal a worrying pattern that warrants urgent preventive actions.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 20568103     DOI: 10.1002/ijc.25525

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Mechanical characterization of cervical squamous carcinoma cells by atomic force microscopy at nanoscale.

Authors:  Yong-xia Ding; Yuan Cheng; Quan-mei Sun; You-yi Zhang; Ke You; Yan-li Guo; Dong Han; Li Geng
Journal:  Med Oncol       Date:  2015-02-19       Impact factor: 3.064

2.  Temporal changes in the cervical cancer burden in Bulgaria: Implications for eastern european countries going through transition.

Authors:  Kaeli K Samson; Gleb Haynatzki; Amr S Soliman; Zdravka Valerianova
Journal:  Cancer Epidemiol       Date:  2016-09-03       Impact factor: 2.984

3.  Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study.

Authors:  Anastasiya Muntyanu; Vladimir Nechaev; Elena Pastukhova; James Logan; Elham Rahme; Elena Netchiporouk; Andrei Zubarev; Ivan V Litvinov
Journal:  Lancet Reg Health Eur       Date:  2022-06-30

Review 4.  Increasing global accessibility to high-level treatments for cervical cancers.

Authors:  C Chargari; M Arbyn; A Leary; N R Abu-Rustum; P Basu; F Bray; S Chopra; R Nout; K Tanderup; A N Viswanathan; C Zacharopoulou; J C Soria; E Deutsch; S Gouy; P Morice
Journal:  Gynecol Oncol       Date:  2021-10-27       Impact factor: 5.304

5.  Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective.

Authors:  Susy M E Scholl; Gemma Kenter; Christian Kurzeder; Philippe Beuzeboc
Journal:  ISRN Oncol       Date:  2011-07-06

6.  The end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012.

Authors:  Marta Cervantes-Amat; Gonzalo López-Abente; Nuria Aragonés; Marina Pollán; Roberto Pastor-Barriuso; Beatriz Pérez-Gómez
Journal:  BMC Cancer       Date:  2015-04-15       Impact factor: 4.430

7.  5-aminolevulinic-acid-based fluorescence spectroscopy and conventional colposcopy for in vivo detection of cervical pre-malignancy.

Authors:  Rasa Vansevičiūtė; Jonas Venius; Olga Žukovskaja; Daiva Kanopienė; Simona Letautienė; Ričardas Rotomskis
Journal:  BMC Womens Health       Date:  2015-04-17       Impact factor: 2.809

8.  Years of life lost due to malignant neoplasms characterized by the highest mortality rate.

Authors:  Malgorzata Pikala; Irena Maniecka-Bryla
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

9.  Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.

Authors:  Chang-Mo Oh; Kyu-Won Jung; Young-Joo Won; Aesun Shin; Hyun-Joo Kong; Jae Kwan Jun; Sang-Yoon Park
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.

Authors:  S Vaccarella; S Franceschi; G Engholm; S Lönnberg; S Khan; F Bray
Journal:  Br J Cancer       Date:  2014-07-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.